Stage IIIC Rectal Cancer Active Not Recruiting Phase 2 Trials for Oxaliplatin (DB00526)

IndicationStatusPhase
DBCOND0028694 (Stage IIIC Rectal Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01871571Bevacizumab, Fluorouracil, Leucovorin Calcium, and Oxaliplatin Before Surgery in Treating Patients With Stage II-III Rectal CancerTreatment